96 related articles for article (PubMed ID: 22098064)
1. Tenofovir plus entecavir as rescue therapy for multidrug-resistant chronic hepatitis B.
Scotto G; D'Addiego G; Giammario A; Campanale F; Fazio V
Liver Int; 2012 Jan; 32(1):171-2. PubMed ID: 22098064
[No Abstract] [Full Text] [Related]
2. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
3. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
4. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.
Amini-Bavil-Olyaee S; Herbers U; Luedde T; Trautwein C; Tacke F
J Viral Hepat; 2011 Nov; 18(11):804-14. PubMed ID: 20887378
[TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.
Rago A; Lichtner M; Mecarocci S; Marocco R; Cenfra N; Belvisi V; Del Borgo C; Cimino G; Mastroianni CM
Antivir Ther; 2010; 15(6):929-32. PubMed ID: 20834107
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
Arasli M; Ustundag Y; Delikanli B; Harmandar F; Buyukuysal C
Hepatogastroenterology; 2012 May; 59(115):851-7. PubMed ID: 22193343
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.
Daudé M; Rostaing L; Sauné K; Lavayssière L; Basse G; Esposito L; Guitard J; Izopet J; Alric L; Kamar N
Transplantation; 2011 Apr; 91(8):916-20. PubMed ID: 21325995
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
9. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.
Shan C; Yin GQ; Wu P
J Med Case Rep; 2014 Aug; 8():281. PubMed ID: 25146249
[TBL] [Abstract][Full Text] [Related]
11. Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
van der Eijk AA; Hansen BE; Niesters HG; Janssen HL; van de Ende M; Schalm SW; de Man RA
J Viral Hepat; 2005 Jul; 12(4):364-72. PubMed ID: 15985006
[TBL] [Abstract][Full Text] [Related]
12. [Entecavir therapy against hepatitis B].
Kato N; Omata M
Nihon Rinsho; 2004 Aug; 62 Suppl 8():340-4. PubMed ID: 15453342
[No Abstract] [Full Text] [Related]
13. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
Asselah T; Marcellin P
Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
[TBL] [Abstract][Full Text] [Related]
14. Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy.
Milazzo L; Corbellino M; Foschi A; Micheli V; Dodero A; Mazzocchi A; Montefusco V; Zehender G; Antinori S
Transpl Infect Dis; 2012 Feb; 14(1):95-8. PubMed ID: 21749588
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults.
Lee HW; Park JY; Ahn SH
Expert Rev Gastroenterol Hepatol; 2016; 10(2):177-86. PubMed ID: 26610256
[TBL] [Abstract][Full Text] [Related]
16. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
17. Approach to chronic hepatitis B virus infection.
Tyagi P; Arora A
JNMA J Nepal Med Assoc; 2011; 51(182):94-101. PubMed ID: 22916521
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B virus resistance to entecavir].
Hidalgo-Tenorio C; Rivero M; Alvarez M; García F
Med Clin (Barc); 2012 Jul; 139(5):228-9. PubMed ID: 22401720
[No Abstract] [Full Text] [Related]
19. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
Sadler MD; Lee SS
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
[No Abstract] [Full Text] [Related]
20. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
Bradshaw D; Danta M
Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
